Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umeclidinium/Vilanterol Effects on Vascular Function in COPD
NCT03611699Phase 4Completed
- Start
- Jan 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Umeclidinium bromide/vilanterol with Placebo (2 arms). Primary endpoints: Carotid artery stiffness at 2 hours and Aortic stiffness at 2 hours. Started Jan 2019; status: completed.
02
Drugs
Anoro Ellipta
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03611699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03611699.